Check out this infographic from the Centers for Disease Control and Prevention (CDC) regarding African-American men and lung cancer.
Radon is the leading cause of lung cancer deaths among nonsmokers in America and claims the lives of about 21,000 Americans each year. In fact, the EPA and the U.S. Surgeon General urge all Americans to protect their health by testing their homes, schools, and other buildings for radon. Radon is an invisible, odorless, tasteless […]
The Radiosurgery Society (RSS), a non-profit medical society dedicated to advancing the science and clinical practice of radiosurgery, recently published a study using data from its RSSearch Patient Registry, a multi-institutional, observational registry established to standardize data collection from patients treated with stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT). The study, titled “Lung […]
According to research from a phase III randomized international study from The University of Texas MD Anderson Cancer Center, patients with operable stage I non-small cell lung cancer (NSCLC) achieved comparable overall survival rates with stereotactic ablative radiotherapy (SABR), also known as stereotactic body radiation therapy (SBRT), rather than the current standard of care, surgery. […]
If your New Year’s resolution to get fit and healthy is already losing steam, February, which is National Cancer Prevention Month, is a great time to give yourself a second chance. Renew your efforts to make healthier choices by learning what you can do to help reduce your cancer risk. The Centers for Disease Control […]
Philadelphia magazine continued their healthcare series about the CyberKnife® Robotic Radiosurgery System with a second online blog post about the new medical treatment that’s changing the way local doctors approach cancer. The blog listed several types of cancers that CyberKnife treats (brain, lung, pancreas, spine, kidney and liver), but mainly focused on prostate cancer, one […]
Philadelphia CyberKnife presented three clinical outcomes research projects at the American College of Radiation Oncology’s 25th annual meeting from May 14 – 16 in Washington, D.C. American College of Radiation Oncology (ACRO) is the essential professional society for success in the day-to-day practice of radiation oncology. ACRO strives to ensure the highest quality care for […]
Noninvasive treatment of tumors that regrow in lung cancer patients is now more possible than ever using CyberKnife® technology. Havertown-based Philadelphia CyberKnife together with Drexel University College of Medicine recently completed a study demonstrating the efficacy of this approach for patients experiencing a recurrence or spread of a lung tumor.
In the last decade, treatment for these diagnoses has progressed using chemotherapy, surgery and external beam radiation therapy, but patients often experience decreased lung functionality following these treatments. The Philadelphia CyberKnife team presented their study at the 2013 National Radiosurgery Society meeting as one of the first of its kind to evaluate this method of treatment for recurrence.
The method uses stereotactic body radiation therapy for recurrent lung cancer patients who have been previously treated with conventional radiation therapy, a process called reirradiation. Results from the study demonstrated patients who received SBRT reirradiation experienced good tumor control at that site and fewer long-term side effects over a three-year period compared with other series of reirradiation.
The U.S. Preventive Services Task Force (USPSTF) recently released a recommendation in favor of CT lung cancer screening for long-term smokers. Though still pending finalization, the recommendation applies to current and heavy smokers between 55 and 79 and could be a huge step in diagnosing high-risk patients sooner. The U.S. Preventive Services Task Force is […]